BioInfoBank Institute
 
Services News Papers Projects FP7 Contact
 

BioInfoBank Institute is a non-for-profit research and development organization. The general objective of the Institute is to generate, incubate and inspire innovative ideas and to facilitate and promote unrestricted and productive research conducted by highly motivated excellent young scientists in Poland. The Institute generates innovative technological solutions. Some of them are converted into commercial project ideas that can be disseminated across the BioInfoBank network. The institute not only educates experts in biotechnology and information technology but also promotes commercial exploitation of scientific discoveries by their own authors through a spin-off program. The main scientific focus of the institute is Bioinformatics, an inter-disciplinary field of science driven by achievements in biotechnology and information technology. The institute is mainly funded by Framework Grants from the European Commission and by grants from the Foundation for Polish Science and from the Polish Ministry of Science.

Main services:

LibraryBioInfoBank Library
Meta Server
Proteins structure and function prediction server
Cancer DrugCancer Drug Server
Ligand InfoSmall molecule meta database and search engine

Latest paper:

Virtual high throughput screening using combined random forest and flexible docking.

We present here the random forest supervised machine learning algorithm applied to flexible docking results from five typical virtual high throughput screening (HTS) studies. Our approach is aimed at: i) reducing the number of compounds to be tested experimentally against the given protein target and ii) extending results of flexible docking experiments performed only on a subset of a chemical library in order to select promising inhibitors from the whole dataset. The random forest (RF) method is applied and tested here on compounds from the MDL drug data report (MDDR). The recall values for selected five diverse protein targets are over 90% and the performance reaches 100%. This machine learning method combined with flexible docking is capable to find 60% of the active compounds for most protein targets by docking only 10% of screened ligands. Therefore our in silico approach is able to scan very large databases rapidly in order to predict biological activity of small molecule inhibitors and provides an effective alternative for more computationally demanding methods in virtual HTS.

Comb Chem High Throughput Screen. 2009 Jun;12 (5):484-9

 
 
 
FP7 Partner
Add BioInfo.PL bioinformatics lab to Your FP7 application
 
BioInfoBank